Hematopoietic stem cell function in a murine model of sickle cell disease

Anemia

Volumn 2012, Issue , 2012, Pages

  Javazon, Elisabeth H ^a   Radhi, Mohamed ^b   Gangadharan, Bagirath ^c   Perry, Jennifer ^c   Archer, David R ^c  

^a MOREHOUSE COLLEGE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MURINAE; MUS;

EID: 84873830925     PISSN: 20901267     EISSN: 20901275     Source Type: Journal    
DOI: 10.1155/2012/387385     Document Type: Article

References (45)

1. Weatherall D. J., Clegg J. B., Inherited haemoglobin disorders: an increasing global health problem. Bulletin of the World Health Organization 2001 79 8 704 712 2-s2.0-0034889014 (Pubitemid 32776838)
2. Malowany J. I., Butany J., Pathology of sickle cell disease. Seminars in Diagnostic Pathology 2012 29 49 55
3. Nur E., Biemond B. J., Otten H. M., Brandjes D. P., Schnog J. J. B., Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management. American Journal of Hematology 2011 86 6 484 489 2-s2.0-79956089142 10.1002/ajh.22012
4. Chirico E. N., Pialoux V., Role of oxidative stress in the pathogenesis of sickle cell disease. IUBMB Life 2012 64 72 80
5. Aslan M., Thornley-Brown D., Freeman B. A., Reactive species in sickle cell disease. Annals of the New York Academy of Sciences 2000 899 375 391 2-s2.0-0034081319 (Pubitemid 30352801)
6. Hebbel R. P., Osarogiagbon R., Kaul D., The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation 2004 11 2 129 151 2-s2.0-3242792093 10.1080/10739680490278402 (Pubitemid 39619075)
7. Kaul D. K., Liu X. D., Zhang X., Ma L., Hsia C. J. C., Nagel R. L., Inhibition of sickle red cell adhesion and vasoocclusion in the microcirculation by antioxidants. American Journal of Physiology 2006 291 1 H167 H175 2-s2.0-33745712683 10.1152/ajpheart.01096.2005
8. Kyle Mack A., Kato G. J., Sickle cell disease and nitric oxide: a paradigm shift? International Journal of Biochemistry and Cell Biology 2006 38 8 1237 1243 2-s2.0-33646184996 10.1016/j.biocel.2006.01.010
9. Somjee S. S., Warrier R. P., Thomson J. L., Ory-Ascani J., Hempe J. M., Advanced glycation end-products in sickle cell anaemia. British Journal of Haematology 2005 128 1 112 118 2-s2.0-12744277978 10.1111/j.1365-2141.2004. 05274.x
10. Ito K., Hirao A., Arai F., Matsuoka S., Takubo K., Hamaguchi I., Nomiyama K., Hosokawa K., Sakurada K., Nakagata N., Ikeda Y., Mak T. W., Suda T., Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 2004 431 7011 997 1002 2-s2.0-7244250309 10.1038/nature02989 (Pubitemid 39434422)
11. Dhalla N. S., Temsah R. M., Netticadan T., Role of oxidative stress in cardiovascular diseases. Journal of Hypertension 2000 18 6 655 673 2-s2.0-0034083227 (Pubitemid 30406736)
12. Valko M., Rhodes C. J., Moncol J., Izakovic M., Mazur M., Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemico-Biological Interactions 2006 160 1 1 40 2-s2.0-32444433202 10.1016/j.cbi.2005.12.009 (Pubitemid 43227479)
13. Finkel T., Holbrook N. J., Oxidants, oxidative stress and the biology of ageing. Nature 2000 408 6809 239 247 2-s2.0-0034626735 10.1038/35041687
14. Muhammad S., Bierhaus A., Schwaninger M., Reactive oxygen species in diabetes-induced vascular damage, stroke, and Alzheimer's disease. Journal of Alzheimer's Disease 2009 16 4 775 785 2-s2.0-67649736148 10.3233/JAD-2009-0982
15. Sugamura K., Keaney J. F. Jr., Reactive oxygen species in cardiovascular disease. Free Radical Biology and Medicine 2011 51 978 992 2-s2.0-79959676505 10.1016/j.freeradbiomed.2011.05.004
16. Allen C. L., Bayraktutan U., Oxidative stress and its role in the pathogenesis of ischaemic stroke. International Journal of Stroke 2009 4 6 461 470 2-s2.0-77449152992
17. Aliyu Z. Y., Tumblin A. R., Kato G. J., Current therapy of sickle cell disease. Haematologica 2006 91 1 7 10 2-s2.0-32544455831
18. Kato G. J., Gladwin M. T., Steinberg M. H., Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Reviews 2007 21 1 37 47 2-s2.0-33846279380 10.1016/j.blre.2006.07.001 (Pubitemid 46110926)
19. Gladwin M. T., Kato G. J., Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia. Hematology 2005 51 57 2-s2.0-33646231295
20. Hebbel R. P., Eaton J. W., Balasingam M., Steinberg M. H., Spontaneous oxygen radical generation by sickle erythrocytes. Journal of Clinical Investigation 1982 70 6 1253 1259 2-s2.0-0020393217 (Pubitemid 13168006)
21. Amer J., Ghoti H., Rachmilewitz E., Koren A., Levin C., Fibach E., Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants. British Journal of Haematology 2006 132 1 108 113 2-s2.0-33644792819 10.1111/j.1365-2141.2005.05834.x (Pubitemid 43381577)
22. Dasgupta T., Hebbel R. P., Kaul D. K., Protective effect of arginine on oxidative stress in transgenic sickle mouse models. Free Radical Biology and Medicine 2006 41 12 1771 1780 2-s2.0-33751530487 10.1016/j.freeradbiomed.2006. 08.025 (Pubitemid 44839141)
23. Brown M. D., Wick T. M., Eckman J. R., Activation of vascular endothelial cell adhesion molecule expression by sickle blood cells. Pediatric Pathology and Molecular Medicine 2001 20 1 47 72 2-s2.0-0035117938 10.1080/ 15227950150502538 (Pubitemid 32168002)
24. Pászty C., Brion C. M., Manci E., Witkowska H. E., Stevens M. E., Mohandas N., Rubin E. M., Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science 1997 278 5339 876 878 2-s2.0-1842408336 10.1126/science.278.5339.876 (Pubitemid 27467927)
25. Noguchi C. T., Gladwin M., Diwan B., Merciris P., Smith R., Yu X., Buzard G., Fitzhugh A., Keefer L. K., Schechter A. N., Mohandas N., Pathophysiology of a sickle cell trait mouse model: human αβ S transgenes with one mouse β -globin allele. Blood Cells, Molecules, and Diseases 2001 27 6 971 977 2-s2.0-0035544703 10.1006/bcmd.2001.0469 (Pubitemid 34163965)
26. Whitney J. B. III, Simplified typing of mouse hemoglobin (Hbb) phenotypes using cystamine. Biochemical Genetics 1978 16 7-8 667 672 2-s2.0-0018160469
27. Kiel M. J., Yilmaz Ö. H., Iwashita T., Yilmaz O. H., Terhorst C., Morrison S. J., SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005 121 7 1109 1121 2-s2.0-21244463426 10.1016/j.cell.2005.05.026 (Pubitemid 40884400)
28. Croizat H., Ponchio L., Nicolini F. E., Nagel R. L., Eaves C. J., Primitive haematopoietic progenitors in the blood of patients with sickle cell disease appear to be endogenously mobilized. British Journal of Haematology 2000 111 2 491 497 2-s2.0-0034537832 10.1046/j.1365-2141.2000.02342.x (Pubitemid 32009341)
29. Amer J., Goldfarb A., Fibach E., Flow cytometric analysis of the oxidative status of normal and thalassemic red blood cells. Cytometry Part A 2004 60 1 73 80 2-s2.0-3042779559 (Pubitemid 38859203)
30. Kean L. S., Manci E. A., Perry J., Balkan C., Coley S., Holtzclaw D., Adams A. B., Larsen C. P., Hsu L. L., Archer D. R., Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease. Blood 2003 102 13 4582 4593 2-s2.0-10744229369 10.1182/blood-2003-03-0712 (Pubitemid 37494128)
31. Khoury R., Abboud M. R., Stem-cell transplantation in children and adults with sickle cell disease: an update. Expert Review of Hematology 2011 4 3 343 351 2-s2.0-79959244335 10.1586/ehm.11.23
32. Walters M. C., Patience M., Leisenring W., Eckman J. R., Scott J. P., Mentzer W. C., Davies S. C., Ohene-Frempong K., Bernaudin F., Matthews D. C., Storb R., Sullivan K. M., Bone marrow transplantation for sickle cell disease. New England Journal of Medicine 1996 335 6 369 376 2-s2.0-9344231922 10.1056/NEJM199608083350601 (Pubitemid 26257244)
33. Walters M. C., Hardy K., Edwards S., Adamkiewicz T., Barkovich J., Bernaudin F., Buchanan G. R., Bunin N., Dickerhoff R., Giller R., Haut P. R., Horan J., Hsu L. L., Kamani N., Levine J. E., Margolis D., Ohene-Frempong K., Patience M., Redding-Lallinger R., Roberts I. A. G., Rogers Z. R., Sanders J. E., Scott J. P., Sullivan K. M., Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. Biology of Blood and Marrow Transplantation 2010 16 2 263 272 2-s2.0-75149170038 10.1016/j.bbmt.2009.10.005
34. Iannone R., Casella J. F., Fuchs E. J., Chen A. R., Jones R. J., Woolfrey A., Amylon M., Sullivan K. M., Storb R. F., Walters M. C., Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β -thalassemia. Biology of Blood and Marrow Transplantation 2003 9 8 519 528 2-s2.0-12144289379 10.1016/S1083-8791(03)00192-7 (Pubitemid 38351796)
35. Horan J. T., Liesveld J. L., Fenton P., Blumberg N., Walters M. C., Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin. Bone Marrow Transplantation 2005 35 2 171 177 2-s2.0-13244269889 10.1038/sj.bmt.1704745 (Pubitemid 40185933)
36. Krishnamurti L., Kharbanda S., Biernacki M. A., Zhang W., Baker K. S., Wagner J. E., Wu C. J., Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease. Biology of Blood and Marrow Transplantation 2008 14 11 1270 1278 2-s2.0-53749086728 10.1016/j.bbmt.2008.08.016
37. Hsieh M. M., Kang E. M., Fitzhugh C. D., Link M. B., Bolan C. D., Kurlander R., Childs R. W., Rodgers G. P., Powell J. D., Tisdale J. F., Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. New England Journal of Medicine 2009 361 24 2309 2317 2-s2.0-71849118976 10.1056/NEJMoa0904971
38. Ito K., Hirao A., Arai F., Takubo K., Matsuoka S., Miyamoto K., Ohmura M., Naka K., Hosokawa K., Ikeda Y., Suda T., Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nature Medicine 2006 12 4 446 451 2-s2.0-33645730667 10.1038/nm1388
39. Ito K., Takubo K., Arai F., Satoh H., Matsuoka S., Ohmura M., Naka K., Azuma M., Miyamoto K., Hosokawa K., Ikeda Y., Mak T. W., Suda T., Hirao A., Regulation of reactive oxygen species by Atm is essential for proper response to DNA double-strand breaks in lymphocytes. Journal of Immunology 2007 178 1 103 110 2-s2.0-33845969499 (Pubitemid 46039661)
40. Saadatzadeh M. R., Bijangi-Vishehsaraei K., Hong P., Bergmann H., Haneline L. S., Oxidant hypersensitivity of fanconi anemia type C-deficient cells is dependent on a redox-regulated apoptotic pathway. Journal of Biological Chemistry 2004 279 16 16805 16812 2-s2.0-1942533379 10.1074/jbc.M313721200 (Pubitemid 38509383)
41. Tothova Z., Kollipara R., Huntly B. J., Lee B. H., Castrillon D. H., Cullen D. E., McDowell E. P., Lazo-Kallanian S., Williams I. R., Sears C., Armstrong S. A., Passegué E., DePinho R. A., Gilliland D. G., FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007 128 2 325 339 2-s2.0-33846419112 10.1016/j.cell.2007.01.003 (Pubitemid 46137992)
42. Kim J., Wong P. K. Y., Loss of ATM impairs proliferation of neural stem cells through oxidative stress-mediated p38 MAPK signaling. Stem Cells 2009 27 8 1987 1998 2-s2.0-69249127963 10.1002/stem.125
43. Kean L. S., Durham M. M., Adams A. B., Hsu L. L., Perry J. R., Dillehay D., Pearson T. C., Waller E. K., Larsen C. P., Archer D. R., A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex-mismatched bone marrow transplantation. Blood 2002 99 5 1840 1849 2-s2.0-0036493491 10.1182/blood.V99.5.1840 (Pubitemid 34533061)
44. Pace B. S., Shartava A., Pack-Mabien A., Mulekar M., Ardia A., Goodman S. R., Effects of N-acetylcysteine on dense cell formation in sickle cell disease. American Journal of Hematology 2003 73 1 26 32 2-s2.0-0242600642 10.1002/ajh.10321 (Pubitemid 36504574)
45. Nur E., Brandjes D. P., Teerlink T., N-acetylcysteine reduces oxidative stress in sickle cell patients. Annals of Hematology. In press